Bluebird Bio Inc (BLUE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 78,744 | 62,305 | 70,651 | 144,067 | 212,047 |
| Receivables | 2,873 | 3,094 | 1,062 | 1,302 | 970 |
| Inventories | 83,283 | 65,017 | 53,944 | 33,330 | 30,305 |
| Other current assets | 1,187 | 13,618 | 17,601 | 14,278 | 16,768 |
| TOTAL | $174,524 | $154,668 | $150,811 | $203,516 | $271,601 |
| Non-Current Assets | |||||
| PPE Net | 60,405 | 60,848 | 62,593 | 78,756 | 90,366 |
| Intangibles | 14,961 | 15,193 | 15,426 | 15,658 | 15,890 |
| Other Non-Current Assets | 46,067 | 229,523 | 236,226 | 247,263 | 253,626 |
| TOTAL | $121,433 | $305,564 | $314,245 | $341,677 | $359,882 |
| Total Assets | $295,957 | $460,232 | $465,056 | $545,193 | $631,483 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 101,540 | 87,167 | 80,680 | 75,063 | 71,515 |
| Accounts payable and accrued liabilities | 42,624 | 34,316 | 24,481 | 30,591 | 19,387 |
| Accrued Expenses | 94,109 | 85,975 | 70,179 | 65,889 | 64,096 |
| TOTAL | $315,078 | $321,462 | $296,032 | $297,930 | $293,573 |
| Non-Current Liabilities | |||||
| Long Term Debt | 15,082 | 7,796 | 5,675 | 19,655 | 26,089 |
| Other Non-Current Liabilities | 23,663 | 162,508 | 169,135 | 174,627 | 180,775 |
| TOTAL | $38,745 | $170,304 | $174,810 | $194,282 | $206,864 |
| Total Liabilities | $353,823 | $491,766 | $470,842 | $492,212 | $500,437 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 9,792 | 9,790 | 9,722 | 9,696 | 9,696 |
| Common Shares | 1,924 | 1,923 | 1,917 | 1,916 | 1,913 |
| Retained earnings | -4,530,112 | -4,501,043 | -4,472,333 | -4,411,525 | -4,330,132 |
| Other shareholders' equity | -1,879 | -2,133 | -1,511 | -2,122 | -2,108 |
| TOTAL | $-57,866 | $-31,534 | $-5,786 | $52,981 | $131,046 |
| Total Liabilities And Equity | $295,957 | $460,232 | $465,056 | $545,193 | $631,483 |